Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials

BACKGROUND: Nearly half of patients with heart failure (HF) have preserved ejection fraction (EF) and the mortality and morbidity of patients with HF with preserved EF (HFpEF) are high. Patients with HFpEF are often elderly and their primary chronic symptom is severe exercise intolerance that result...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuta, Hidekatsu, Hagiwara, Hiromi, Kamiya, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399288/
https://www.ncbi.nlm.nih.gov/pubmed/36032269
http://dx.doi.org/10.1016/j.ijcha.2022.101103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399288/
https://www.ncbi.nlm.nih.gov/pubmed/36032269
http://dx.doi.org/10.1016/j.ijcha.2022.101103

Ejemplares similares